Flora Zagouri
Flora Zagouri
Verified email at
Cited by
Cited by
Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer
S Modi, W Jacot, T Yamashita, J Sohn, M Vidal, E Tokunaga, J Tsurutani, ...
New England Journal of Medicine 387 (1), 9-20, 2022
Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting
F Amant, P Berveiller, IA Boere, E Cardonick, R Fruscio, M Fumagalli, ...
Annals of Oncology 30 (10), 1601-1612, 2019
Trastuzumab administration during pregnancy: a systematic review and meta-analysis
F Zagouri, TN Sergentanis, D Chrysikos, CA Papadimitriou, ...
Breast cancer research and treatment 137, 349-357, 2013
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
HA Azim Jr, S Michiels, F Zagouri, S Delaloge, M Filipits, M Namer, ...
Annals of oncology 24 (3), 647-654, 2013
Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors
MA Dimopoulos, M Roussou, M Gavriatopoulou, F Zagouri, M Migkou, ...
Clinical Lymphoma and Myeloma 9 (4), 302-306, 2009
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis
F Zagouri, TN Sergentanis, R Bartsch, AS Berghoff, D Chrysikos, ...
Breast cancer research and treatment 139, 13-22, 2013
Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease
X Provatopoulou, A Gounaris, E Kalogera, F Zagouri, I Flessas, ...
BMC cancer 9, 1-7, 2009
Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis
F Zagouri, TN Sergentanis, D Chrysikos, R Bartsch
Obstetrics & Gynecology 121 (2 PART 1), 337-343, 2013
Cancer in pregnancy: disentangling treatment modalities
F Zagouri, C Dimitrakakis, S Marinopoulos, A Tsigginou, MA Dimopoulos
ESMO open 1 (3), e000016, 2016
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre …
F André, YH Park, SB Kim, T Takano, SA Im, G Borges, JP Lima, S Aksoy, ...
The Lancet 401 (10390), 1773-1785, 2023
Quantitative diffusion-weighted imaging of the bone marrow: an adjunct tool for the diagnosis of a diffuse MR imaging pattern in patients with multiple myeloma
V Koutoulidis, S Fontara, E Terpos, F Zagouri, D Matsaridis, D Christoulas, ...
Radiology 282 (2), 484-493, 2017
Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development
GE Theodoropoulos, V Saridakis, T Karantanos, NV Michalopoulos, ...
The Breast 21 (4), 534-538, 2012
Risk factors for multiple myeloma: a systematic review of meta-analyses
TN Sergentanis, F Zagouri, G Tsilimidos, A Tsagianni, M Tseliou, ...
Clinical Lymphoma Myeloma and Leukemia 15 (10), 563-577. e3, 2015
Molecularly targeted therapies in cervical cancer. A systematic review
F Zagouri, TN Sergentanis, D Chrysikos, M Filipits, R Bartsch
Gynecologic oncology 126 (2), 291-303, 2012
Current clinical practice guidelines for the treatment of renal cell carcinoma: a systematic review and critical evaluation
A Bamias, B Escudier, CN Sternberg, F Zagouri, A Dellis, B Djavan, ...
The oncologist 22 (6), 667-679, 2017
Taxanes for breast cancer during pregnancy: a systematic review
F Zagouri, TN Sergentanis, D Chrysikos, C Dimitrakakis, A Tsigginou, ...
Clinical Breast Cancer 13 (1), 16-23, 2013
Hsp90 inhibitors in breast cancer: a systematic review
F Zagouri, TN Sergentanis, D Chrysikos, CA Papadimitriou, ...
The Breast 22 (5), 569-578, 2013
High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
F Zagouri, Z Bago-Horvath, F Rössler, A Brandstetter, R Bartsch, ...
British journal of cancer 108 (5), 1100-1105, 2013
Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma
F Zagouri, TN Sergentanis, GC Zografos
World Journal of Surgical Oncology 5, 1-11, 2007
Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma
E Kastritis, F Zagouri, A Symeonidis, M Roussou, A Sioni, A Pouli, ...
Leukemia 28 (10), 2075-2079, 2014
The system can't perform the operation now. Try again later.
Articles 1–20